it is a good thing..A wholly owned subsidiary is a separate entity, since the SEC Radient Filings prove that ADI is now a Division.. sales from Uni are not separated from shareholders thanks to mac and Akio ...What you will see is ProvistaDX taking over the RXPC shell while Mac Akio and William heading the ADI Division..The deal with PDX is ADI will pay the accounts payable and the lenders, PDX angel investors, and longs RXPC shares will be exchanged for ProvistaDX shares..Most likely a 1 to 2.25 ration..1 share of Provista for 2.25 shares of RXPC... imo Wolfman Jack
DC You are right on the mark..The Radient-Diagnostics and GCDX web sites are smoke screens..GCDX will take the place of ADI and ProvistaDX in place of the Radient corporation once the reverse merger is finalized.....That is why the Radient Pharmaceuticals name can be used by another source..That name is gone..We told you that a year ago, because if it was relevant, Mac would have trademarked Radient and AMDL ....The Global Cancer name fits perfect with ADI since that is the Corporation Mac has DR-70 trademarked and the Uni Pharma agreement..The reason Mac did this separation is to keep the RXPC a clean shell..imo Wolf Pack
livinginsv Thursday, 10/30/14 07:58:53 PM
Re: guardiangel post# 25891
Post # of 25894
ADI, separating UNI sales from RXPC shareholders . . . how can this be considered good? . .
